Asthma Sample Clauses

Asthma. The following services related to asthma are covered with $0 Out-of-Pocket Cost when linked to a primary diagnosis of asthma and performed by a Network Provider: • Office visits to a Primary Care Provider for routine management of asthma • Office visits to a Pulmonologist (lung specialist) for consultation and routine management of asthma • Office visits to an Allergist (allergy specialist) for consultation and routine management of asthma • Palliative care conversations (chronic condition treatment preferences) with Primary Care Provider, Pulmonologist, or Allergist • Immunotherapy for allergen sensitization to reduce impact and severity of allergic reactions • Inhaler adjuncts (e.g., spacer) as specified on the formulary and dispensed through our Home Delivery Program • Pulmonary function tests • Asthma education [allergens/triggers, asthma action plan and behavioral modification counseling] • Targeted laboratory tests for the routine management of asthma Please note, if you have complications from asthma and use an urgent care center, emergency department, or have a Hospital stay, services will be subject to standard Out-of-Pocket Costs as outlined in your Schedule of Benefits.
Sample 1Sample 2See All (5)
AutoNDA by SimpleDocs
Asthma. Asthma is a chronic, incurable disease which causes many symptoms that make breathing difficult [3]. Around 5% of the Medicare population in the Parkview area is affected by asthma, as well a portion of the population of adults and children. Asthma as a chief health concern was not mentioned in the community or provider surveys, but asthma in the Medicare population appeared as a primary concern in several of the seven counties according to HCI. While the population affected may be small, the disease burden is high due to expensive and potentially life-long costs associated with managing symptoms of asthma. There are several clinical intervention strategies recommended by healthcare professionals to reduce the frequency and severity of symptoms. Table 5: Asthma Xxxxx Xxxxxxxxxx Kosciusko LaGrange Noble Wabash Xxxxxxx Asthma 5.6% 6% 4.5% 3.6% 5.5% 4.8% 5.5% *In Medicare population
Sample 1Sample 2Sample 3
Asthma. Since phthalates are well-known endocrine disruptors, a large amount of research focuses on effects on the reproductive system, the thyroid and metabolism (Huang, Kuo, Guo, Liao, & Xxx, 2007; Lyche et al., 2009). We are interested in its influence on respiratory system. Asthma, characterized by recurrent bronchial hyperresponsiveness, is one of most common pulmonary diseases in the Xxxxxx Xxxxxx. Xx 0000-0000, asthma prevalence was 8.8% among adults. Overall asthma prevalence among adults increased from 2001-2002 (7.1%) to 2013-2014 (9.2%) (CDC). Common clinical symptoms of asthma include coughing, wheezing, shortness of breath and chest tightness. Symptoms are typically exacerbated at night and in the early morning or related to exercise or inspiration of cold air in winter. Airway inflammation, airflow obstruction, and irreversible airway remodeling are believed to be involved in asthma development. The respiratory system of a human contains two lungs, the trachea, the bronchi in the mediastinum, and the bronchial trees (bronchi branches). The trachea and its large proximal branches form a passageway for air exchange between the lung and the external environment (Gilroy, 2013). Asthma primarily targets at the bronchi and its subdivisions and conducting bronchioles. The pathogenesis of asthma can be classified into two categories. One is intrinsic asthma mainly caused by viral infection (e.g., rhinovirus, parainfluenza virus, respiratory syncytial virus), air pollutants, aspirin or other nonsteroidal medication use (Goljan, 2013). The other one is extrinsic asthma which involves a classical inflammation process. Mast cells, IgE antibodies, leukotrienes, chemokines and cytokines participate in the inflammation process and lead to histologic changes, such as thickening of the basement membranes, infiltration of inflammatory cells, hypertrophy of mucous glands, hypertrophy of smooth muscle cells and hyperplasia (Kumar, Abbas, & Aster, 2012). Narrowing of the bronchi causes expiratory wheezing in asthma, and the air trapping in distal bronchioles leads to the increased anteroposterior thoracic diameter, especially in long-term untreated asthma patients. Although the mechanisms have not yet been elucidated, there are several encouraging laboratory research findings pertaining to the cellular mechanisms through which phthalates may influence inflammation and allergic response. For example, the production of pro-inflammatory chemokines and cytokines in human mac...
Sample 1
Asthma. Implement targeted education and outreach activities to increase awareness of and disseminate resources on childhood asthma management, including management before, during and after a disaster. Grantee will:
Sample 1
Asthma 
Sample 1

Related to Asthma

  • Treatment Program Testing The Employer may request or require an employee to undergo drug and alcohol testing if the employee has been referred by the employer for chemical dependency treatment or evaluation or is participating in a chemical dependency treatment program under an employee benefit plan, in which case the employee may be requested or required to undergo drug or alcohol testing without prior notice during the evaluation or treatment period and for a period of up to two years following completion of any prescribed chemical dependency treatment program.

  • Study An application for leave of absence for professional study must be supported by a written statement indicating what study or research is to be undertaken, or, if applicable, what subjects are to be studied and at what institutions.

  • Health Screening The Contractor shall conduct a Health Needs Screen (HNS) for new members that enroll in the Contractor’s plan. The HNS will be used to identify the member’s physical and/or behavioral health care needs, special health care needs, as well as the need for disease management, care management and/or case management services set forth in Section 3.8. The HNS may be conducted in person, by phone, online or by mail. The Contractor shall use the standard health screening tool developed by OMPP, i.e., the Health Needs Screening Tool, but is permitted to supplement the OMPP Health Needs Screening Tool with additional questions developed by the Contractor. Any additions to the OMPP Health Needs Screening Tool shall be approved by OMPP. The HNS shall be conducted within ninety (90) calendar days of the Contractor’s receipt of a new member’s fully eligible file from the State. The Contractor is encouraged to conduct the HNS at the same time it assists the member in making a PMP selection. The Contractor shall also be required to conduct a subsequent health screening or comprehensive health assessment if a member’s health care status is determined to have changed since the original screening, such as evidence of overutilization of health care services as identified through such methods as claims review. Non-clinical staff may conduct the HNS. The results of the HNS shall be transferred to OMPP in the form and manner set forth by OMPP. As part of this contract, the Contractor shall not be required to conduct HNS for members enrolled in the Contractor’s plan prior to January 1, 2017 unless a change in the member’s health care status indicates the need to conduct a health screening. For purposes of the HNS requirement, new members are defined as members that have not been enrolled in the Contractor’s plan in the previous twelve (12) months. Data from the HNS or NOP form, current medications and self-reported medical conditions will be used to develop stratification levels for members in Hoosier Healthwise. The Contractor may use its own proprietary stratification methodology to determine which members should be referred to specific care coordination services ranging from disease management to complex case management. OMPP shall apply its own stratification methodology which may, in future years, be used to link stratification level to the per member per month capitation rate. The initial HNS shall be followed by a detailed Comprehensive Health Assessment Tool (CHAT) by a health care professional when a member is identified through the HNS as having a special health care need, as set forth in Section 4.2.4, or when there is a need to follow up on problem areas found in the initial HNS. The detailed CHAT may include, but is not limited to, discussion with the member, a review of the member’s claims history and/or contact with the member’s family or health care providers. These interactions shall be documented and shall be available for review by OMPP. The Contractor shall keep up-to-date records of all members found to have special health care needs based on the initial screening, including documentation of the follow-up detailed CHAT and contacts with the member, their family or health care providers.

  • Human Leukocyte Antigen Testing This plan covers human leukocyte antigen testing for A, B, and DR antigens once per member per lifetime to establish a member’s bone marrow transplantation donor suitability in accordance with R.I. General Law §27-20-36. The testing must be performed in a facility that is: • accredited by the American Association of Blood Banks or its successors; and • licensed under the Clinical Laboratory Improvement Act as it may be amended from time to time. At the time of testing, the person being tested must complete and sign an informed consent form that also authorizes the results of the test to be used for participation in the National Marrow Donor program.

  • System Impact Study An assessment by the Transmission Provider of (i) the adequacy of the Transmission System to accommodate a Completed Application, an Interconnection Request or an Upgrade Request, (ii) whether any additional costs may be incurred in order to provide such transmission service or to accommodate an Interconnection Request, and (iii) with respect to an Interconnection Request, an estimated date that an Interconnection Customer’s Customer Facility can be interconnected with the Transmission System and an estimate of the Interconnection Customer’s cost responsibility for the interconnection; and (iv) with respect to an Upgrade Request, the estimated cost of the requested system upgrades or expansion, or of the cost of the system upgrades or expansion, necessary to provide the requested incremental rights.

  • Screening 3.13.1 Refuse containers located outside the building shall be fully screened from adjacent properties and from streets by means of opaque fencing or masonry walls with suitable landscaping.

  • Random Drug Testing All employees covered by this Agreement shall be subject to random drug testing in accordance with Appendix D.

  • Clinical 2.1 Provides comprehensive evidence based nursing care to patients including assessment, intervention and evaluation.

  • Service Animals Humber Residences acknowledges the rights of persons with disabilities to retain their service animal while living in Residence. In order to preserve the health and safety of all people and animals living or working in the Residence environment, the Resident will notify the Residence Office that they require a service animal and will provide documentation as outlined in the Accessibility for Ontarians with Disabilities Act confirming that the Resident requires the service animal. The Resident will also complete a Service Animal Agreement with the Residence Manager or designate, and agrees to adhere to the requirements within it.

  • Medication 1. Xxxxxxx’s physician shall prescribe and monitor adequate dosage levels for each Client.

Time is Money Join Law Insider Premium to draft better contracts faster.